Vivace Therapeutics, Inc. — Form D/A
Vivace Therapeutics, Inc. of San Mateo, CA, a company, filed a Form D amendment with the SEC on 2018-05-01. The offering totals $25.0M, of which $8.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-05-01
- Form: D/A
- Accession: 0001630575-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $25.0M
- Amount sold: $8.0M
- Remaining: $17.0M
- Investors: 6
- Date of first sale: 2017-05-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-287006
Issuer
- Name: Vivace Therapeutics, Inc.
- CIK: 0001630575
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 1510 Fashion Island Blvd., Suite 310, San Mateo, CA, 94404
- Phone: 858-344-7499
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Leonard Post | Executive Officer | Edmonton, A0 |
| Leonard Post | Director | Edmonton, A0 |
| Edward Hu | Director | San Mateo, CA |
| Jun Wu | Director | San Mateo, CA |
| Jake Simson | Director | San Mateo, CA |
| Tim Shannon | Director | Westport, CT |
| Chenguang Zhou | Director | San Mateo, CA |
| Shuang Qiao | Director | San Mateo, CA |
| Shuang Qiao | Executive Officer | San Mateo, CA |
| Sheng Ding | Executive Officer | Orinda, CA |
Other filings by this issuer (4)
More